Announcement on Completion of Administration of the First Subject in Phase I Clinical Trial of GLR2037 Tablets

About this update from Gan & Lee Pharmaceuticals Co., Ltd. Class A

Announcement on Completion of Administration of the First Subject in Phase I Clinical Trial of GLR2037 Tablets The abstract is for reference only. Please refer to the full text of the announcement on the very day. Link of Full Text for Reference: View Attachment

View stock analysis, news, and events for Gan & Lee Pharmaceuticals Co., Ltd. Class A